Why choose tiotropium for my patient? A comprehensive review of actions and outcomes versus other bronchodilators

Why choose tiotropium for my patient? A comprehensive review of actions and outcomes versus other bronchodilators

Purpose Chronic obstructive pulmonary disease (COPD) and asthma are leading causes of morbidity and mortality. This narrative review provides an appraisal of the pharmacological and clinical characteristics of tiotropium in COPD and asthma, and examines how these compare with other long-acting bronc...

Full description

Bibliographic Details
Main Authors:	Halpin, D, Kaplan, A, Russell, R
Format:	Journal article
Published:	Elsevier 2017

Similar Items

Combined bronchodilators (tiotropium plus olodaterol) for patients with chronic obstructive pulmonary disease
by: Ramadan WH, et al.
Published: (2015-10-01)

Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium
by: Owen Roger, et al.
Published: (2010-10-01)

Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the moRnING)
by: Marin JM, et al.
Published: (2016-06-01)

Tiotropium in asthma: what is the evidence and how does it fit in?
by: David M.G. Halpin
Published: (2016-01-01)

When is dual bronchodilation indicated in COPD?
by: Thomas M, et al.
Published: (2017-08-01)

Patient-reported outcomes of dual bronchodilator fixed-dose combination versus bronchodilator monotherapy in individuals with COPD
by: Strange C, et al.
Published: (2019-06-01)

Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study
by: Ichinose M, et al.
Published: (2018-07-01)

Improvement in 24-hour bronchodilation and symptom control with aclidinium bromide versus tiotropium and placebo in symptomatic patients with COPD: post hoc analysis of a Phase IIIb study
by: Beier J, et al.
Published: (2017-06-01)

Cost-Effectiveness Analysis of Fixed-Dose Tiotropium/Olodaterol versus Tiotropium for COPD Patients in China
by: Lan Y, et al.
Published: (2023-09-01)

Observational study on the impact of initiating tiotropium alone versus tiotropium with fluticasone propionate/salmeterol combination therapy on outcomes and costs in chronic obstructive pulmonary disease
by: Chatterjee Arjun, et al.
Published: (2012-02-01)

Tiotropium - Advancing the treatment of COPD
by: Chambers, S, et al.
Published: (2008)

A comparative study of bronchodilator response: utilizing pre-bronchodilator versus predicted normal values
by: Afe Alexis, et al.
Published: (2024-01-01)

Beyond Dual Bronchodilation – Triple Therapy, When and Why
by: Cazzola M, et al.
Published: (2022-01-01)

Tiotropium in COPD: clinical outcomes and economic evidence
by: Orietta Zaniolo, et al.
Published: (2010-03-01)

Bronchodilator reversibility testing in morbidly obese non-smokers: fluticasone/salmeterol efficacy versus salbutamol bronchodilator
by: Mona Ibrahim Ahmed, et al.
Published: (2023-10-01)

The future of bronchodilation: looking for new classes of bronchodilators
by: Mario Cazzola, et al.
Published: (2019-12-01)

Why Choosing Philosophy?
by: Andrea Vestrucci
Published: (2020-08-01)

Chest Pain Relieved with a Bronchodilator or Other Asthma Drugs
by: Hirokazu Taniguchi, et al.
Published: (2009-01-01)

Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
by: Zafar Zafari, et al.
Published: (2018-01-01)

Comparative effectiveness of triple therapy versus dual bronchodilation in COPD
by: Jaco Voorham, et al.
Published: (2019-08-01)

Why choose BJPsych Bulletin?
by: Andrew Forrester
Published: (2024-06-01)

Tiotropium HandiHaler® and Respimat® in COPD: a pooled safety analysis
by: Halpin DMG, et al.
Published: (2015-02-01)

The evolving role of tiotropium in asthma
by: McIvor ER, et al.
Published: (2017-08-01)

Choosing Actions
by: David A. Rosenbaum, et al.
Published: (2013-06-01)

COST-EFFECTIVENESS OF VILANEROL / UMECLIDINIUM VERSUS TIOTROPIUM IN SEVERE AND VERY SEVERE COPD
by: E. G. Kosolapov, et al.
Published: (2017-08-01)

Choose MyPlate: Reduce Your Sodium
by: Ashley Hamm, et al.
Published: (2013-04-01)

Choose MyPlate: Reduce Your Sodium
by: Shari Bresin, et al.
Published: (2021-11-01)

Choose MyPlate: Reduce Your Sodium
by: Ashley Hamm, et al.
Published: (2013-04-01)

Choose MyPlate: Reduce Your Sodium
by: Shari Bresin, et al.
Published: (2021-11-01)

Choose MyPlate: Reduce Your Sodium
by: Ashley Hamm, et al.
Published: (2013-04-01)

Choosing the Right Interpreter: Reflections on My Experience
by: Melody Schwantes
Published: (2015-06-01)

A real-world evaluation of indacaterol and other bronchodilators in COPD: the INFLOW study
by: Juvelekian G, et al.
Published: (2015-10-01)

Evaluating the cost-effectiveness of tiotropium versus salmeterol in the treatment of chronic obstructive pulmonary disease
by: Shalini Naik, et al.
Published: (2010-03-01)

Tiotropium as essential maintenance therapy in COPD
by: M. Decramer
Published: (2006-12-01)

Inhibition of granulocyte migration by tiotropium bromide
by: Randerath Winfried J, et al.
Published: (2011-02-01)

Efficacy of tiotropium in the prevention of exacerbations of COPD
by: Antonio Anzueto, et al.
Published: (2009-06-01)

Bronchodilator efficacy of 18 µg once-daily tiotropium inhalation via Discair® versus HandiHaler® in adults with chronic obstructive pulmonary disease: randomized, active-controlled, parallel-group, open-label, Phase IV trial
by: Yildiz P, et al.
Published: (2016-11-01)

Two versus four puffs of albuterol: does dose change bronchodilator response?
by: McLaughlin AV, et al.
Published: (2019-01-01)

Mimosa pudica extracts as bronchodilator /
by: M. Zaini Asmawi, et al.

COPD - moving beyond bronchodilation
by: Swiss Medical Weekly
Published: (2007-03-01)